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618-Pos Board B398
Role of TRPV1 Channels in Glioma Cell Viability and Survival Yelena Nersesyan, Swapna Asuthkar, Kiran K. Velpula, Xiaohui Sun, Lusine Demirkhanyan, Eleonora Zakharian. University of Illinois, College of Medicine, Peoria, IL, USA. High grade primary brain tumors are among the deadliest malignancies known to medicine. Anaplastic gliomas (WHO grade 3) and Glioblastoma Multiforme, or GBM, (WHO grade 4) are prevalent primary brain tumors in adults. Exploration of new avenues in treatment of GBM is absolutely crucial when taking into consideration the short (12-17 months) survival time after the diagnosis. Annually there are around 20,000 new cases, including over 4,000 pediatric (age 0-19) cases. The heat and capsaicin receptor TRPV1 is highly expressed in malignant gliomas, where the channels are thought to play a role in inducing apoptotic cell death. We evaluated TRPV1 expression in different glioma cell lines and determined the correlation of the protein expression with age and sex in the tissue samples obtained from patients with GMB. We found that age dependent correlation of TRPV1 expression is more characteristic for male patients with GBM than for females. However, in both groups TRPV1 expression was higher in patients of age 35-55 years old. We also investigated the sensitivity of different glioma cell lines to the TRPV1 agonists, including endovanilloid NADA and capsaicin. We found that 50 mM of capsaicin inhibited the cell growth and proliferation of U87 but not U251 glioma cells. The presence of TRPV1 on the plasma membrane was higher in U87 cells in comparison to U251, as confirmed by biotinylation, and may account for the effect of capsaicin on the cell viability. These results indicate that TRPV1 could play an important role in regulating Ca 2þ homeostasis of primary brain tumors.
619-Pos Board B399
Dietary Capsaicin and Exercise: Analysis of a Two-Pronged Approach to Counteract Obesity Vivek Krishnan, Kevin Fettel, Baskaran Thyagarajan. University of Wyoming, Laramie, WY, USA. Obesity contributes to diabetes, hypertension and myocardial infarction. Exercise is an effective measure to counteract obesity. Recent research demonstrates a regulatory role of transient receptor potential vanilloid 1 (TRPV1) in high fat diet (HFD)-induced obesity. Here, we evaluated the effects of exercise 5 dietary capsaicin (CAP, 0.01% of total HFD), an active ingredient in natural chili peppers and a TRPV1 agonist, on HFD-fed wild type and TRPV1-/-(TRPV1 knockout) mice. We evaluated the performance of normal chow diet (NCD) or HFD (5CAP)-fed mice on computercontrolled rotarod. Trained mice were exercised for 12 min./day for five days a week. HFDþCAP-fed mice walked on the rotarod for a longer duration of the exercise regimen (630 5 69 sec.) and showed lesser weight gain after 25 weeks of feeding (11.5 5 2.1 g) compared to exercised HFD-fed mice (440 5 215 sec.; 27.5 5 2.1 g). Both sedentary and exercised HFDfed groups exhibited similar weight gain, albeit an increase in food consumption shown by exercised HFD-fed group. Also, exercised HFD þ CAP-fed mice showed an increased metabolic activity compared to exercised HFD-fed group. Further, NCD-fed WT mice walked for longer duration on the rotarod (704 5 14 sec) and gained lesser weight at 20 weeks of feeding (4.5 5 0.7 g) than NCD-fed TRPV1-/-mice (665 5 50 sec.; 7.7 5 2.1 g). CAP prevented weight gain to a similar extent in both sedentary and exercised wild type mice. Also, Dietary CAP improved the endurance of mice on rotarod and counteracted HFD-induced suppression of muscle coordination. This suggests a novel role of TRPV1 in metabolism and muscle coordination function. Collectively, our data provide evidence for the role of TRPV1 and its activation by dietary CAP and exercise to inhibit HFD-induced obesity.
620-Pos Board B400
Proton as a Dual Regulator for TRPV1 Bo Hyun Lee, Jie Zheng. Physiology & Membrane Biology, UC Davis, Davis, CA, USA. TRPV1 is a pain-sensing polymodal receptor. In the body core where temperature is stable and capsaicin is normally absent, extracellular H þ (from tissue injury, inflammation, ischemia, etc.) serves as the best-known endogenous ligand. While H þ is known to strongly activate TRPV1, the underlying mechanism is still unclear. We observe two opposing effects of H þ : it strongly potentiates activation gating but inhibits ion permeation. The combination of these two effects produces a smaller current upon acidification and a prominent OFF response when H þ is removed. The permeation effect is voltage-dependent, indicating that H þ binds in the conducting pore to cause block. Correlations between TRPV1 cryo-EM structures and functional effects of point mutations allow us to investigate the mechanism underlying H þ -mediated permeation block. Inhibition of ion permeation substantially shifts the macroscopic dose-response relationship for H þ activation, which needs to be corrected for the study of gating effects.
621-Pos Board B401
Unraveling Allosteric Coupling Mechanisms in the TRPV1 Channel Andrés Jara-Oseguera 1 , Kenton J. Swartz 2 . 1 Molecular Physiology and Biophysics section, NINDS, NIH, Bethesda, MD, USA, 2 Molecular Physiology and Biophysics Section, NINDS, NIH, Bethesda, MD, USA. The TRPV1 channel is a homotetrameric non-selective cation channel that functions in nociceptors as an integrator of external noxious stimuli and endogenous pro-inflammatory signaling molecules. The diversity of its modulators is staggering, including voltage, lipids, protons, cations, temperature, protein kinases, oxidizing and reducing agents and protein toxins. Structural perturbations throughout the receptor and some antagonists have been shown to selectively ablate specific modalities of channel activation without entirely disrupting others, suggesting that most stimuli use distinct molecular mechanisms for regulating the channel. Nevertheless, most stimuli that activate TRPV1 are strongly coupled, exhibiting synergy in both their efficacy and affinity. Here we studied the effects of small extracellular monovalent cations, which had been shown to inhibit channel activity, on temperature-, proton-and capsaicindependent activation of the TRPV1 channel. We found that substitution of extracellular sodium or potassium with N-methyl-D-glucamine has a strong effect on channel temperature sensitivity, shifting the threshold of activation to lower temperatures by > 20 C and causing a 5-10-fold reduction in Q10. However, we also found that both heat and capsaicin can overcome the inhibitory effects of sodium and lead to channel activation in a sodium-independent manner once the cation-inhibitory site has reached saturation, suggesting these stimuli act through distinct mechanisms. In contrast, the potentiating effect of protons at pH < 6 seems to be dependent on sodium concentration. We are currently performing experiments under elevated sodium conditions on proton-associated TRPV1 mutants to determine whether protons modulate the channel by two different mechanisms that cause channel activation or potentiation, and whether sodium is involved in either of these. TRPV1 is a capsaicin receptor with exquisite selectivity and sensitivity. How capsaicin binds and drives channel activation remain poorly understood. The TRPV1 cryo-EM structures at apo and capsaicin bounded state show clearly conformational rearrangements near the binding site, however the ligand itself is registered as a small volume that reflects neither the molecule's whole chemical structure nor specific ligand-channel interactions. Using an iterative approach of computational modeling by Rosetta and functional tests such as double-mutant cycle analysis, we found that the vanillyl moiety and amide group of capsaicin form specific interactions with the channel that fix their positions. The hydrophobic tail contributes to binding energy through non-specific hydrophobic interactions but may sample a range of conformations, making it invisible in an averaged structure. State-specific interactions between the ligand and TRPV1 suggest dynamic conformational transitions that may underlie the molecular mechanism of ligand driven activation.
622-Pos
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Insight into the Structure of Tetramer hTRPV1 from Homology Modeling, Molecular Docking, Molecular Dynamics Simulation and Virtual Screening Zhiwei Feng. Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA. Transient receptor potential vanilloid type 1 (TRPV1) is a heatactivated cation channel protein, which contributes to inflammation, acute 124a Sunday, February 8, 2015
and persistent pain. Antagonists of human TRPV1 (hTRPV1) represent a novel therapeutic approach for the treatment of pain. Developing various antagonists of hTRPV1, however, has been hindered by the unavailability of a 3D structure of hTRPV1. Recently, the structure of rat TRPV1 have been reported and it shares 85.7% sequence identity with hTRPV1. In the present work, we constructed and reported a 3D homology tetramer model of hTRPV1 based on the cryo-EM structures of rTRPV1. Molecular dynamics (MD) simulations, energy minimizations, and prescreen were applied to select and validate the best model of hTRPV1. The predicted binding pocket of hTRPV1 consists of two adjacent monomers, which were congruent with the experimental data and the cyro-EM structures of rTRPV1. The detailed interactions between hTRPV1 and its antagonists or agonists were characterized by molecular docking. Conformational changes of hTRPV1 upon antagonist/agonist binding were also explored by MD simulation. The different movements of compounds led to different conformational changes of monomers in hTRPV1, indicating that TRPV1 works in a concerted way. We observed that the selective filter was open when hTRPV1 bound with an agonist during MD simulation. For the lower gate of hTRPV1, we observed large similarities between hTRPV1 of agonist-bound and of antagonist bound. A five-point pharmacophore model based on several antagonists was developed and the structural model was used to predict new antagonists for hTRPV1. By using the 3D TRPV1 structure model above, we have performed in-silico screening and identified candidate compounds which are currently being characterized both for binding affinity and for functional activity on human TRPV1 (NIH R01DA025612 and P30DA035778). Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) has been recognized as an important activator of certain transient receptor potential (TRP) channels. More specifically, TRPV1 is a pain receptor activated by a wide range of stimuli. However, whether or not PI(4,5)P 2 is a TRPV1 agonist remains open to debate. Utilizing a combined approach of mutagenesis and molecular modeling, we identified a PI(4,5)P 2 binding site located between the TRP box and the S4-S5 linker. At this site PI(4,5)P 2 interacts with the amino acid residues R575 and R579 in the S4-S5 linker and with K694 in the TRP box. We confirmed that PI(4,5)P 2 behaves as a channel agonist and found that R575, R579 and K694 mutations to alanine reduce PI(4,5)P 2 binding affinity. Additionally, in silico mutations R575A, R579A and K694A showed that the reduction in binding affinity results from the delocalization of PI(4,5)P 2 in the binding pocket. Molecular dynamics simulations indicate that PI(4,5)P 2 binding induces conformational rearrangements of the structure formed by S6 and the TRP domain, which leads to the opening of the lower TRPV1 channel gate.
624-Pos
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Preparation and Evaluation of PLGA Coated Capsaicin Magnetic Nanoparticles for Target Site-Specific Pain Therapeutics Mrudhula Baskaran 1 , Baskaran Thyagarajan 2 . 1 Laramie High School, Laramie, WY, USA, 2 Pharmacy, University of Wyoming, Laramie, WY, USA. Pain accompanies several diseases including arthritis, cancer, diabetes, and often manifests as a disease itself. Currently, narcotic and non-narcotic drugs that are used to treat pain have several unwanted side effects due to their addiction, use dependence, and systemic side effects. A potential solution is to develop a target site-specific magnetic nanoparticle based delivery of analgesics. Transient Receptor Potential Vanilloid 1 (TRPV1; capsaicin receptor) is a non-selective cation channel protein, which mediates nociceptive pain and inflammation and is a target to develop therapeutics against chronic pain. Capsaicin, an ingredient of hot chili peppers, desensitizes TRPV1 and inhibits noxious pain. Here, we present the development and characterization of capsaicin magnetic nanoparticles (CMN) for site-specific pain therapeutics. Poly-L-lactide coglycollide (PLGA) coated CMN (PCMN) was prepared by solvent evaporation/coprecipitation technique and determined the size of CMN by transmission electron microscopy. Further, we determined the drug loading, encapsulation efficiency and pharmacokinetic release profiles of capsaicin from PCMN in vitro and examined the ability of PCMN to activate TRPV1, by intracellular Ca 2þ imaging. Thermogram of CMN and crystalline nature of capsaicin were determined by differential scanning calorimetry and x-ray diffraction techniques, respectively. Next, we analyzed the intracellular localization of nanoparticles using fluorescein as a model drug. Finally, we characterized the anti-nociceptive potential of PCMN by intraplantar injection of PCMN in mice model of inflammation and pain. Our data demonstrate that PLGA coated CMN can be developed as a novel sitespecific analgesic. Currently, we are investigating the site-specific action of PCMN under the influence of an external magnetic field. This novel method of drug-delivery will revolutionize therapeutics, since it will prevent the undesired side effects.
626-Pos Board B406
Dissociation Rates as One of the Differentiating Factors for Hyperthermic and Non-Hyperthermic TRPV1 Antagonists Laykea Tafesse 1 , Gang Wu 1 , Kevin Carlin 1 , Toshiyuki Asaki 2 , Toshiyuki Kanemasa 2 , Victor Ilyin 1 . 1 Discovery Research, Purdue Pharma L. P., Cranbury, NJ, USA, 2 Shionogi Research Laboratories, Osaka, Japan. In addition to pain sensation, both thermal regulation and thermosensation are thought to be influenced by TRPV1 channel functioning. Involvement of TRPV1 in these latter physiological functions became clear during pharmaceutical development of selective TRPV1 antagonists for the treatment of chronic painful conditions. The majority of TRPV1 antagonists that have been progressed into clinical trials were reported to increase body temperature (hyperthermia) in healthy humans. Currently, hyperthermia is a major concern in pharmaceutical development of TRPV1 antagonists. We therefore sought of an in-vitro method to identify compounds with a low hyperthermic potential early in the drug discovery process. Using whole-cell patch clamp electrophysiology on human TRPV1 expressing CHO cells, we performed kinetic measurements of dissociation from the receptor of known hyperthermic (AMG517 and ABT102) and non-hyperthermic (SB705498) TRPV1 antagonists. We found that AMG517 and ABT102, two hyperthermic compounds, exhibited slow off-(dissociation) rates when channels were activated by capsaicin. Conversely, the non-hyperthermic compound SB705498, showed a significantly faster rate of dissociation from the receptor. Finally, we assessed an in-house proprietary antagonist V116517 which demonstrated significant separation between analgesic efficacy and hyperthermia. Once again, this compound displayed a faster off-rate as compared to the hyperthermic compounds. With these initial findings we hypothesize that the dissociation rate of an antagonist from the TRPV1 channel is an important parameter in determining a compound's effect on thermal regulation and thermosensation. Antagonists with a fast off-rate may allow endogenous ligands to interact with the TRPV1 channel and thereby fulfil its physiological role in body temperature regulation while still effectively modifying pain signaling. In conclusion, our findings suggest that in vitro kinetic measurements early in the drug discovery process may be a useful means of identifying non-hyperthermic TRPV1 antagonists.
627-Pos Board B407
A Single-Residue Switch for High Temperature Dependence of Thermal TRPV3 Channels Beiying Liu, Feng Qin. SUNY-Buffalo, Buffalo, NY, USA. Thermal TRP channels, a group of ion channels from the transient receptor potential family, play important functions in pain transduction and thermal sensation. The channels are directly activated by temperature, with strong temperature dependence. However, how temperature gates these channels remains poorly understood. One characteristic feature of some thermal TRP channels is hysteresis of gating. This is perhaps most prominent in vanilloid receptor TRPV3. The channel is initially only responsive to extreme heat with low activity, and only after repeated stimulation it becomes vigorously responsive to warm temperatures. Importantly, the hysteresis of activation is accompanied with a profound loss of the high temperature dependence of the channel, suggesting that the hysteresis involves structural changes in temperature sensing. Elucidation of such changes will therefore provide an opportunity to unravel the molecular mechanism underlying temperature sensing of thermal channels. Here we examine the molecular basis underlying hysteresis of heat activation of TRPV3. We show that the hysteresis is mediated by an N terminal domain proximal to membranes, the same region that we have
